Literature DB >> 197421

Antiviral T cell-mediated immunity in Marek's disease.

L J Ross.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 197421     DOI： 10.1038/268644a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.

Authors:  K K Murthy; B W Calnek
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

Review 2.  Immunology of Guillain-Barré syndrome.

Authors:  I Steiner; O Abramsky
Journal:  Springer Semin Immunopathol       Date:  1985

3.  In vitro cytotoxicity against Marek's disease lymphoblastoid cell lines after enzymatic removal of Marek's disease tumor-associated surface antigen.

Authors:  K A Schat; K K Murthy
Journal:  J Virol       Date:  1980-04       Impact factor: 5.103

4.  Depression of vaccinal immunity to Marek's disease by infection with reticuloendotheliosis virus.

Authors:  R L Witter; L F Lee; L D Bacon; E J Smith
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

5.  A theory of virus-induced demyelination in the Landry-Guillain-Barré syndrome.

Authors:  J S Pepose
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

6.  Marek's disease as a model for the Landry--Guillain--Barré syndrome: latent viral infection in nonneuronal cells accompanied by specific immune responses to peripheral nerve and myelin.

Authors:  J S Pepose; J G Stevens; M L Cook; P W Lampert
Journal:  Am J Pathol       Date:  1981-05       Impact factor: 4.307

7.  B cells do not play a role in vaccine-mediated immunity against Marek's disease.

Authors:  Mohammad Heidari; Huanmin Zhang; Cari Hearn; Lakshmi Sunkara
Journal:  Vaccine X       Date:  2021-12-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.